Prediction models for exacerbations in patients with COPD
Open Access
- 18 January 2017
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 26 (143) , 160061
Abstract
Personalised medicine aims to tailor medical decisions to the individual patient. A possible approach is to stratify patients according to the risk of adverse outcomes such as exacerbations in chronic obstructive pulmonary disease (COPD). Risk-stratified approaches are particularly attractive for drugs like inhaled corticosteroids or phosphodiesterase-4 inhibitors that reduce exacerbations but are associated with harms. However, it is currently not clear which models are best to predict exacerbations in patients with COPD. Therefore, our aim was to identify and critically appraise studies on models that predict exacerbations in COPD patients. Out of 1382 studies, 25 studies with 27 prediction models were included. The prediction models showed great heterogeneity in terms of number and type of predictors, time horizon, statistical methods and measures of prediction model performance. Only two out of 25 studies validated the developed model, and only one out of 27 models provided estimates of individual exacerbation risk, only three out of 27 prediction models used high-quality statistical approaches for model development and evaluation. Overall, none of the existing models fulfilled the requirements for risk-stratified treatment to personalise COPD care. A more harmonised approach to develop and validate high- quality prediction models is needed to move personalised COPD medicine forward.Keywords
This publication has 59 references indexed in Scilit:
- Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary DiseaseJAMA, 2013
- A comparison of three multidimensional indices of COPD severity as predictors of future exacerbationsInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelinesBMC Medicine, 2013
- Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohortsBMJ Open, 2012
- Clinical predictors of exacerbation frequency in chronic obstructive pulmonary diseaseThe Clinical Respiratory Journal, 2010
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysisBMC Medicine, 2009